<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01555320</url>
  </required_header>
  <id_info>
    <org_study_id>201007001-02</org_study_id>
    <nct_id>NCT01555320</nct_id>
  </id_info>
  <brief_title>Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure</brief_title>
  <acronym>CACT-IHF</acronym>
  <official_title>Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure (CACT-IHF) A Randomized, Double-blind, Multicenter, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State Administration of Traditional Chinese Medicine of the People's Republic of China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State Administration of Traditional Chinese Medicine of the People's Republic of China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      CACT-IHF aims to evaluate the clinical efficacy and safety of Qishen Yiqi Dripping Pills in
      treating ischemic heart failure. Meeting the diagnosis, inclusion and exclusion criteria, the
      study plans to recruit 640 cases from 35 upper class hospitals in China, who are divided into
      two groups (treatment and control group) by central randomization service. The treatment
      group will be administrated with one bag of Qishen Yiqi Dripping Pills (0.52g/bag) three
      times a day in addition to standardized western medications. Whereas the control group will
      be given one bag of Qishen Yiqi Dripping Pills dummy (0.52g/bag) three times a day in
      addition to standardized western medications. Efficacy indicators include primary indicator
      (6 minute walk test) and secondary indicators: composite endpoint consisting of all-cause
      death, emergency/re-admission to hospital due to HF, frequency of re-admission due to
      cardiovascular disease, acute coronary syndrome, severe arrhythmia, cardiac shock,
      revascularization, stroke, pulmonary embolism and peripheral vascular incidences, etc.; Brain
      Natriuretic Peptide; echocardiography; cardiothoracic ratio; NYHA cardiac function
      classification; Minnesota life quality scale; scores from the four traditional chinese
      medicine (TCM) diagnostic methods). Other indicators include blood cholesterol, triglyceride,
      high density cholesterol and low density cholesterol. Safety indicators include blood
      pressure, heart rate, blood and urine routine tests, liver and renal function tests, serum
      electrolytes, electrocardiogram and adverse events. All of the patients will receive
      interventional drug treatment for 6 months. Follow up is needed on the 1st, 3rd, 6th, 9th,
      12th month after recruitment. All patients will be followed up until the end of study (Refers
      to the 12th month of the last case recruited into the study).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6MWT distance</measure>
    <time_frame>0 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>6MWT</measure>
    <time_frame>3rd month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>6MWT</measure>
    <time_frame>6th month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite endpoint</measure>
    <time_frame>1st,3rd,6th,9th,12th month</time_frame>
    <description>all-cause death, frequency of emergency/re-admission to hospital due to HF, frequency of re-admission due to cardiovascular disease, acute coronary syndrome, severe arrhythmia, cardiac shock, revascularization, stroke, pulmonary embolism and peripheral vascular incidences, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain natriuretic peptide (BNP)</measure>
    <time_frame>0,6th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography</measure>
    <time_frame>0,6th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiothoracic Ratio(CR)</measure>
    <time_frame>0,6th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function classification, NYHA</measure>
    <time_frame>0,1st,3rd,6th,9th,12th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minnesota life quality scale</measure>
    <time_frame>0,1st,3rd,6th,9th,12th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores from the four TCM diagnostic methods</measure>
    <time_frame>0,1st,3rd,6th,9th,12th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood and urine routine tests,liver and renal function tests,serum electrolytes,electrocardiogram (ECG)</measure>
    <time_frame>0,3rd,6thmonth</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">640</enrollment>
  <condition>Ischemic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Qishen Yiqi dripping pills dummy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Qishen Yiqi Dripping Pills</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Qishen Yiqi Dripping Pills</intervention_name>
    <description>One packet of Qishen Yiqi Dripping Pills (0.52g) will be given three times a day in addition to regular western medications for the first 6 months, and regular western medications only for the subsequent 6 months.</description>
    <arm_group_label>Qishen Yiqi Dripping Pills</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Qishen Yiqi dripping pills dummy</intervention_name>
    <description>One packet of Qishen Yiqi Dripping Pills dummy (0.52g) will be given three times a day in addition to regular western medications for the first 6 months, and regular western medications only for the subsequent 6 months.</description>
    <arm_group_label>Qishen Yiqi dripping pills dummy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 40 to 79

          -  Patients with ischemic heart failure：

               -  LVEF less than or equal to 45% measured by echocardiography in modified Simpson
                  method

               -  History of prior myocardial infarction with or without percutaneous coronary
                  intervention (PCI) or/and coronary artery bypass grafting (CABG);

               -  Coronary angiography (CAG) or coronary CTA shows more than or equal to 50%
                  stenosis in at least one of the main coronary arteries with or without
                  revascularization, of which the researcher thinks that it is closely related to
                  heart failure;

               -  With or without dyspnea, fatigue and fluid retention (edema) etc.

          -  History of heart failure or present with heart failure symptoms for at least 3 months;

          -  New York Heart Association (NYHA) Class II to IV;

          -  Submitted informed consent

        Exclusion Criteria:

          -  Acute heart failure or acute exacerbation of chronic heart failure

          -  Those who have one of the following diseases:

               -  Acute coronary syndrome within 30 days

               -  Revascularization therapy within 6 months

               -  Uncontrolled hypertension with systolic pressure more than or equal to 180mmHg
                  and/or diastolic pressure more than or equal to 110mmHg

               -  Second degree type 2 or worse sinoatrial/atrioventricular block without
                  implantation of pacemaker or uncontrolled malignant cardiac arrhythmia

               -  Dilated cardiomyopathy

               -  Hypertrophic obstructive cardiomyopathy

               -  Myocarditis

               -  Pulmonary artery embolism

               -  Severe valvular heart disease

               -  Pulmonary heart disease

               -  Stroke within 6 months

          -  Cardiac resynchronization therapy

          -  Applied diuretics, cardiotonic agents or vasodilators intravenously within 7 days

          -  Severe endocrine diseases such as hyperthyroidism, etc.

          -  History of malignant tumor

          -  Hemoglobin (HB )≤ 9g/dl

          -  Alanine aminotransferase (ALT) &gt; 2 times the upper limit of normal

          -  Serum creatinine &gt; 265 μmol/L

          -  Mental disorder

          -  Being pregnant, planning for pregnancy or breastfeeding

          -  Suspicious or definite allergy to intervention drugs

          -  Participated in other trials within 2 months

          -  Unable to walk autonomously due to physical disabilities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jingyuan Mao, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Teaching Hospital of Tianjin University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yazhu Hou, Dr.</last_name>
    <phone>8622-27432325</phone>
    <email>mreleven@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yao Han, Dr.</last_name>
      <email>Hanyao1212@126.com</email>
    </contact>
    <investigator>
      <last_name>Hongxu Liu, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bingqi Wei, Dr.</last_name>
      <email>weibing918q@sina.com</email>
    </contact>
    <investigator>
      <last_name>Jian Zhang, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xiyuan Hospital of China Academy of Chinese Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yang Miao, Dr.</last_name>
      <email>Miya9@163.com</email>
    </contact>
    <investigator>
      <last_name>Yang Miao, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial Hospital of TCM</name>
      <address>
        <city>Guangdong</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaogang Sheng, Dr.</last_name>
      <email>shengxiaogang1@sina.com.cn</email>
    </contact>
    <investigator>
      <last_name>Huanlin Wu, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second Affiliated Hospital of TCM College Guiyang</name>
      <address>
        <city>Guiyang</city>
        <state>Guizhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tingchun Wu, Dr.</last_name>
      <email>649164263@qq.com</email>
    </contact>
    <investigator>
      <last_name>Tao Xu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>252 Hospital of Chinese People's Liberation Army</name>
      <address>
        <city>Baoding</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuebin Cao, Dr.</last_name>
      <email>cxb13633227588@126.com</email>
    </contact>
    <investigator>
      <last_name>Xuebin Cao, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The 1st Affiliated Hospital of Heilongjiang Traditional Chinese Medicine University</name>
      <address>
        <city>Heilongjiang</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Wang, Dr.</last_name>
      <email>19911737@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Yang Li, Dr.</last_name>
      <email>19911737@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yabin Zhou, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Henan University of TCM</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tinghai Du, Dr.</last_name>
      <email>dth2010@163.com</email>
    </contact>
    <investigator>
      <last_name>Mingjun Zhu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Nanhua Hospital of Nanhua University</name>
      <address>
        <city>Hengyang</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huan Liu, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Xiaofeng Ma, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Traditional Chinese Medicine Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bo Zhu, Dr.</last_name>
      <email>najahannah@sina.com</email>
    </contact>
    <investigator>
      <last_name>Xiaohu Chen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nanjing Hospital of T.C.M</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhongxing Shao, Dr.</last_name>
      <email>Szx790102@sohu.com</email>
    </contact>
    <investigator>
      <last_name>Ning Gu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Jiangxi University of TCM</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peng Deng, Dr.</last_name>
      <email>dengpeng615@sina.com</email>
    </contact>
    <investigator>
      <last_name>Zhongyong Liu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital To Changchun University of Chinese Medicine</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yudan Tian, Dr.</last_name>
      <email>30880356@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yue Deng, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yaqiu Jiang, Dr.</last_name>
      <email>yaqiujiang@163.com</email>
    </contact>
    <investigator>
      <last_name>Yaqiu Jiang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Liaoning University of Traditional Chinese Medicine</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ying Yang, Dr.</last_name>
      <email>Yang_ying_2002@sina.com</email>
    </contact>
    <investigator>
      <last_name>Fengrong Wang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Ding, Dr.</last_name>
      <email>chensn@sj-hospital.org</email>
    </contact>
    <investigator>
      <last_name>Suning Chen, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haiyan Shan, Dr.</last_name>
      <email>shanhy024@163.com</email>
    </contact>
    <investigator>
      <last_name>Xiaojuan Bai, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donghai Wang, Dr.</last_name>
      <email>fine_dongbo@163.com</email>
    </contact>
    <investigator>
      <last_name>Bo Dong, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second Affiliated Hospital of Shaanxi University of Chinese Medicine</name>
      <address>
        <city>Xianyang</city>
        <state>Shaanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Qi</last_name>
      <email>404317104@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yonggang Wang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shandong Province Traditional Chinese Medicine University Affiliated Hospital</name>
      <address>
        <city>Shandong</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunlun Li, Dr.</last_name>
      <email>liyunlun@163.com</email>
    </contact>
    <investigator>
      <last_name>Yitao Xue</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qingfen Zhou, Dr.</last_name>
      <email>zhouqingfen@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Fengru Zhang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Shuguang Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongming Liu, Dr.</last_name>
      <email>liuyongming@foxmail.com</email>
    </contact>
    <investigator>
      <last_name>Xiaolong Wang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Traditional Chinese Medicine Hospital of Shan Xi Province</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tianfu Niu, Dr.</last_name>
      <email>niutianfu2584@sina.com</email>
    </contact>
    <investigator>
      <last_name>Tianfu Niu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Teaching Hospital of Chengdu University of TCM</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Jiang, Dr.</last_name>
      <email>cdwwx729@163.com</email>
    </contact>
    <investigator>
      <last_name>Weixing Wang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Medical College of Chinese People's Armed Police Forces</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Tian, Dr.</last_name>
      <email>Tianjun6666@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Tiemin Jiang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First Teaching Hospital of Tianjin University of Traditional Chinese Medicine</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yazhu Hou</last_name>
      <email>mreleven@163.com</email>
    </contact>
    <investigator>
      <last_name>Jingyuan Mao, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second Affiliated Hospital of Tianjin University of TCM</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Wang, Dr.</last_name>
      <email>Wangtao973@163.com</email>
    </contact>
    <investigator>
      <last_name>Yingqiang Zhao, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The 2nd Hospital of Tianjin Medical University</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruyu Yuan, Dr.</last_name>
      <email>tjcardio@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ruyu Yuan, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tian Jin Chest Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Geng, Dr.</last_name>
      <email>gengjie_1973@126.com</email>
    </contact>
    <investigator>
      <last_name>Shutao Chen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tianjin Academy of Traditional Chinese Medicine Affliated Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chuanhui Huang, Dr.</last_name>
      <email>huangchuanhui66@sina.com</email>
    </contact>
    <investigator>
      <last_name>Ruihong Fan, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Traditional Chinese Medical Hospital of Xinjiang Uyghur Autonomous Region</name>
      <address>
        <city>Urumqi</city>
        <state>Xinjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongqing An, Dr.</last_name>
      <email>wxf87112008@163.com</email>
    </contact>
    <investigator>
      <last_name>Xiaofeng Wang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Anhui University of TCM</name>
      <address>
        <city>Anhui</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhengbin Shao, Dr.</last_name>
      <email>shaozhengbin@126.com</email>
    </contact>
    <investigator>
      <last_name>Xiaohua Dai, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dong Fang Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinjin Lu, Dr.</last_name>
      <email>Lu2008jinjin@126.com</email>
    </contact>
    <investigator>
      <last_name>Yang Wu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 29, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <last_update_submitted>March 19, 2013</last_update_submitted>
  <last_update_submitted_qc>March 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Teaching Hospital of Tianjin University of Traditional Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Jingyuan Mao</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

